Similar articles

• Successful chemoimmunotherapy of murine L1210 lymphatic leukemia with cyclophosphamide and mafosfamide-treated leukemia cells.

  Kawalec M, Skórski T, Kawiak J. Kawalec M, et al. Invest New Drugs. 1988 Sep;6(3):169-72. doi: 10.1007/BF00175393. Invest New Drugs. 1988. PMID: 3192382
• Chemotherapy and immunotherapy of L1210 leukemic mice with antigenic tumor sublines.

  Nicolin A, Canti G, Marelli O, Veronese F, Goldin A. Nicolin A, et al. Cancer Res. 1981 Apr;41(4):1358-62. Cancer Res. 1981. PMID: 7011535
• Superiority of Micrococcus lysodeikticus to BCG in chemo-immunotherapy of advanced L1210 leukaemia.

  Verloes R, Atassi G. Verloes R, et al. Eur J Cancer Clin Oncol. 1981 Aug;17(8):849-56. doi: 10.1016/0014-2964(81)90304-2. Eur J Cancer Clin Oncol. 1981. PMID: 6799298 No abstract available.
• Discussion paper: experimental and clinical immunopharmacology data applicable to cancer immunotherapy.

  Mathé G, Schwarzenberg L, Halle-Pannenko O, Simmler MC. Mathé G, et al. Ann N Y Acad Sci. 1976;277(00):467-84. doi: 10.1111/j.1749-6632.1976.tb41721.x. Ann N Y Acad Sci. 1976. PMID: 826207 Review. No abstract available.
• Immunochemotherapy of human cancer.

  Gutterman JU, Mavligit GM, Reed RC, Hersh EM. Gutterman JU, et al. Semin Oncol. 1974 Dec;1(4):409-23. Semin Oncol. 1974. PMID: 4620443 Review. No abstract available.